Selangor, Malaysia

Cian Ying Tung

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Skinprotect Corporation Sdn Bhd. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cian Ying Tung. Retrieved from https://idiyas.com/inventor/cian-ying-tung-8wrwtycs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Cian Ying Tung

Introduction: Cian Ying Tung, a talented inventor hailing from Selangor, Malaysia, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Cian Ying Tung has recently been granted several patents for his cutting-edge inventions in the realm of artificial intelligence and renewable energy technologies.

Career Highlights: Throughout his illustrious career, Cian Ying Tung has demonstrated a remarkable ability to transform bold ideas into tangible solutions. His work has significantly impacted various industries, from healthcare to sustainable energy.

Collaborations: Cian Ying Tung has collaborated with leading research institutions and tech companies worldwide, fostering a culture of innovation and pushing the boundaries of what is possible in the world of technology.

Conclusion: Cian Ying Tung's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His legacy as a visionary inventor is sure to endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…